Abstract
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by abnormally elevated levels of blood glucose. The hyperglycemic condition is caused by abnormalities in either insulin secretion, insulin action, or both. Two-thirds of diabetes-related deaths are caused by atherosclerotic cardiovascular disease (ASCVD).
Objective: The purpose of this study was to determine the risk of ASCVD and related factors in type 2 DM patients in Medan, North Sumatra.
Methods: We conducted a cross-sectional observational study. A total of 252 DM patients visiting primary health centers in Medan were recruited after fulfilling the inclusion and exclusion criteria. The level of risk of atherosclerotic cardiovascular disease (ASCVD) was determined by using ASCVD Risk Calculator. Data required to use this calculator are age, sex, race, total cholesterol, HDL-C, systolic blood pressure, diastolic blood pressure, history of diabetes, history of hypertension treatment, smoking history, and use of statins for anti-hyperlipidemia. The data were then analyzed with Chi-square Test (p < 0.0%) and processed with SPSS.
Results: There were 59 (23.41%), 140 (55.56%), and 53 (21.03%) participants who had high, moderate, and low risks of ASCVD, respectively. Bivariate analysis showed significant association between risk of ASCVD with age, SBP, total cholesterol level, HDL-C levels, and duration of diabetes (p < 0.05). Meanwhile, gender and familial history not related to ASCVD risks among DM patients (p > 0.05).
Conclusion: The risks for atherosclerotic complications of cardiovascular disease in type 2 DM patients in Medan were predominantly high. The variables related to ASCVD risks included age, gender, HbA1C, systolic blood pressure (SBP), total cholesterol levels, HDL-C, and LDL-C levels.
[1]
Goyal R, Jialal I. Diabetes Mellitus Type 2. 2022 Jun 19. StatPearls. Treasure Island, FL: StatPearls Publishing 2022.
[2]
Vargas E, Joy NV, Carrillo Sepulveda MA. Biochemistry, Insulin Metabolic Effects. StatPearls. Treasure Island (FL): StatPearls Publishing 2021.
[3]
International Diabetes Federation. IDF Diabetes Atlas (10th ed.), 2021. Available from: https://www.diabetesatlas.org
[4]
INFODATIN. Data and Information Center of the Indonesian Ministry of Health. Stay Productive, Prevent and Overcome Diabetes Mellitus Jakarta 2020. Available from: https://pusdatin.kemkes.go.id/resources/download/pusdatin/infodatin/Infodatin-2020-Diabetes-Melitus.pdf
[5]
Dal Canto E, Ceriello A, Rydén L, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 2019; 26 (Suppl. 2): 25-32.
[http://dx.doi.org/10.1177/2047487319878371] [PMID: 31722562]
[http://dx.doi.org/10.1177/2047487319878371] [PMID: 31722562]
[6]
Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular disease in diabetes mellitus. Circulation 2016; 133(24): 2459-502.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022194] [PMID: 27297342]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022194] [PMID: 27297342]
[7]
Fan W. Epidemiology in diabetes mellitus and cardiovascular disease. Cardiovasc Endocrinol 2017; 6(1): 8-16.
[http://dx.doi.org/10.1097/XCE.0000000000000116] [PMID: 31646113]
[http://dx.doi.org/10.1097/XCE.0000000000000116] [PMID: 31646113]
[8]
Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012: 1-30.
[http://dx.doi.org/10.1155/2012/918267] [PMID: 22611498]
[http://dx.doi.org/10.1155/2012/918267] [PMID: 22611498]
[9]
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation 2019; 140(11): e596-646.
[http://dx.doi.org/10.1161/CIR.0000000000000678] [PMID: 30879355]
[http://dx.doi.org/10.1161/CIR.0000000000000678] [PMID: 30879355]
[10]
Unnikrishnan AG, Sahay RK, Phadke U, et al. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PLoS One 2022; 17(3): e0263619.
[http://dx.doi.org/10.1371/journal.pone.0263619] [PMID: 35358208]
[http://dx.doi.org/10.1371/journal.pone.0263619] [PMID: 35358208]
[11]
Crisafulli A, Pagliaro P, Roberto S, et al. Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning. Int J Mol Sci 2020; 21(8): 2896.
[http://dx.doi.org/10.3390/ijms21082896] [PMID: 32326182]
[http://dx.doi.org/10.3390/ijms21082896] [PMID: 32326182]
[12]
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17(1): 83.
[http://dx.doi.org/10.1186/s12933-018-0728-6] [PMID: 29884191]
[http://dx.doi.org/10.1186/s12933-018-0728-6] [PMID: 29884191]
[13]
Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 19 million people. Lancet Diabetes Endocrinol 2015; 3(2): 105-13.
[http://dx.doi.org/10.1016/S2213-8587(14)70219-0] [PMID: 25466521]
[http://dx.doi.org/10.1016/S2213-8587(14)70219-0] [PMID: 25466521]
[14]
Ikhsan YK, Soelistijo SA, Putranto JNE. Profile of cardiovascular disease risk in type 2 diabetes mellitus patients receiving statin therapy: A cross-sectional study. Ann Med Surg 2022; 75(6): 103368.
[http://dx.doi.org/10.1016/j.amsu.2022.103368] [PMID: 35242320]
[http://dx.doi.org/10.1016/j.amsu.2022.103368] [PMID: 35242320]
[15]
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: Process, indicators, risk factors and new hopes. Int J Prev Med 2014; 5(8): 927-46.
[PMID: 25489440]
[PMID: 25489440]
[16]
Maharani A, Sujarwoto , Praveen D, Oceandy D, Tampubolon G, Patel A. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. PLoS One 2019; 14(4): e0215219.
[http://dx.doi.org/10.1371/journal.pone.0215219] [PMID: 31039155]
[http://dx.doi.org/10.1371/journal.pone.0215219] [PMID: 31039155]
[17]
Head T, Daunert S, Goldschmidt-Clermont PJ. The aging risk and atherosclerosis: A fresh look at arterial homeostasis. Front Genet 2017; 8(DEC): 216.
[http://dx.doi.org/10.3389/fgene.2017.00216] [PMID: 29312440]
[http://dx.doi.org/10.3389/fgene.2017.00216] [PMID: 29312440]
[18]
Cavender MA, Steg PG, Smith SC Jr, et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: Outcomes at 4 years from the reduction of atherosclerosis for continued health (REACH) registry. Circulation 2015; 132(10): 923-31.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014796] [PMID: 26152709]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014796] [PMID: 26152709]
[19]
Gidding SS, Allen NB. Cholesterol and atherosclerotic cardiovascular disease: A lifelong problem. J Am Heart Assoc 2019; 8(11): e012924.
[http://dx.doi.org/10.1161/JAHA.119.012924] [PMID: 31137996]
[http://dx.doi.org/10.1161/JAHA.119.012924] [PMID: 31137996]
[20]
Quispe R, Elshazly MB, Zhao D, et al. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol 2020; 27(15): 1597-605.
[http://dx.doi.org/10.1177/2047487319862401] [PMID: 31291776]
[http://dx.doi.org/10.1177/2047487319862401] [PMID: 31291776]
[21]
Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: Inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci 2012; 1254(1): 18-32.
[http://dx.doi.org/10.1111/j.1749-6632.2012.06480.x] [PMID: 22548566]
[http://dx.doi.org/10.1111/j.1749-6632.2012.06480.x] [PMID: 22548566]
[22]
März W, Kleber ME, Scharnagl H, et al. HDL cholesterol: Reappraisal of its clinical relevance. Clin Res Cardiol 2017; 106(9): 663-75.
[http://dx.doi.org/10.1007/s00392-017-1106-1] [PMID: 28342064]
[http://dx.doi.org/10.1007/s00392-017-1106-1] [PMID: 28342064]
[23]
Annema W, von Eckardstein A. Dysfunctional high-density lipoproteins in coronary heart disease: Implications for diagnostics and therapy. Transl Res 2016; 173: 30-57.
[http://dx.doi.org/10.1016/j.trsl.2016.02.008] [PMID: 26972566]
[http://dx.doi.org/10.1016/j.trsl.2016.02.008] [PMID: 26972566]
[24]
Nakanishi R, Baskaran L, Gransar H, et al. Relationship of hypertension to coronary atherosclerosis and cardiac events in patients with coronary computed tomographic angiography. Hypertension 2017; 70(2): 293-9.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09402] [PMID: 28607128]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09402] [PMID: 28607128]
[25]
Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension 2020; 75(2): 285-92.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14240]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14240]
[26]
Zhou Y, Zhang R, Wang G, et al. Coexistence effect of hypertension and angiotensin II on the risk of coronary heart disease: A population-based prospective cohort study among Inner Mongolians in China. Curr Med Res Opin 2019; 35(8): 1473-8.
[http://dx.doi.org/10.1080/03007995.2019.1601430] [PMID: 30917708]
[http://dx.doi.org/10.1080/03007995.2019.1601430] [PMID: 30917708]
[27]
Lo S, Leiter LA, Langer A, et al. Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration? J Diabetes Complications 2021; 35(10): 107997.
[http://dx.doi.org/10.1016/j.jdiacomp.2021.107997] [PMID: 34332851]
[http://dx.doi.org/10.1016/j.jdiacomp.2021.107997] [PMID: 34332851]
[28]
Tesfaye A, Josef H, Wube TB, et al. Magnitude of, and factors associated with cardiovascular disease among type two diabetes mellitus patients. Diabetes Metab Syndr Obes 2020; 13: 4123-9.
[http://dx.doi.org/10.2147/DMSO.S254883] [PMID: 33177852]
[http://dx.doi.org/10.2147/DMSO.S254883] [PMID: 33177852]
[29]
Matheus ASM, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: An update. Int J Hypertens 2013; 2013: 1-15.
[http://dx.doi.org/10.1155/2013/653789] [PMID: 23533715]
[http://dx.doi.org/10.1155/2013/653789] [PMID: 23533715]
[30]
Amelia R, Harahap J, Lelo A, Wijaya H, Harahap N, Yamamoto Z. Risk analysis for cardiovascular complication based on the atherogenic index of plasma of type 2 diabetes mellitus patients in Medan, Indonesia. Fam Medi Primary Care Rev 2020; 22(3): 197-201.
[http://dx.doi.org/10.5114/fmpcr.2020.98242]
[http://dx.doi.org/10.5114/fmpcr.2020.98242]
[31]
Zhang H, Qin L, Sheng CS, et al. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk. BMJ Open Diabetes Res Care 2020; 8(1): e000810.
[http://dx.doi.org/10.1136/bmjdrc-2019-000810] [PMID: 31958299]
[http://dx.doi.org/10.1136/bmjdrc-2019-000810] [PMID: 31958299]
[32]
Alharithy MK, Alobaylan MM, Alsugair ZO, Alswat KA. Impact of family history of diabetes on diabetes control and complications. Endocr Pract 2018; 24(9): 773-9.
[http://dx.doi.org/10.4158/EP-2018-0071] [PMID: 30308135]
[http://dx.doi.org/10.4158/EP-2018-0071] [PMID: 30308135]
[33]
Hermans MP, Ahn SA, Rousseau MF. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring. J Diabetes 2019; 11(4): 301-8.
[http://dx.doi.org/10.1111/1753-0407.12840] [PMID: 30105804]
[http://dx.doi.org/10.1111/1753-0407.12840] [PMID: 30105804]
[34]
Mühlenbruch K, Menzel J, Dörr M, et al. Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts. Sci Rep 2020; 10(1): 15373.
[http://dx.doi.org/10.1038/s41598-020-72361-4] [PMID: 32958955]
[http://dx.doi.org/10.1038/s41598-020-72361-4] [PMID: 32958955]
